# REEV

> REEV is a medical robotics company building AI-powered wearable robotics to restore everyday mobility for people with neurological gait disorders after stroke, multiple sclerosis or paraplegia. Its flagship DREEVEN is a lightweight (about 3kg) motorized knee orthosis driven by electro-hydraulic actuation and real-time gait sensing, paired with REEV SENSE, an IMU wearable that turns a person's walking pattern into clinical-grade gait reports. Founded in 2021 and split between Boston and Toulouse, REEV raised $9.2M in February 2025 to finalize DREEVEN, run a clinical study at Boston University and prepare for FDA trials.

- **Founded:** 2021
- **Headquarters:** Boston, United States (with R&D in Toulouse, France)
- **Founders:** Amaury Ciurana (Co-Founder & CEO), Robin Temporelli (Co-Founder & CTO)
- **Team size:** ~30-37 employees across Boston and Toulouse
- **Products:** DREEVEN, REEV SENSE
- **Notable:** Raised $9.2M in February 2025 to advance DREEVEN toward FDA trials., Selected for Techstars 2023 and NVIDIA Inception., Finalist in the Massachusetts MeHI Healthy Aging Challenge.

## Products & services

- **DREEVEN** — An AI-powered motorized knee orthosis for people with gait disorders. It weighs around 3kg, uses ultra-precise electro-hydraulic actuation and real-time gait sensing to predict the wearer's movement milliseconds in advance, delivering exactly the assistance needed for walking, sitting, standing and climbing stairs.
- **REEV SENSE** — A wearable IMU motion sensor that clips to a patient's shoe or leg and runs embedded gait-analysis algorithms, sending clinical-grade gait biomarker reports (speed, cadence, stride length, swing/stance time, symmetry) to a mobile app for patients and clinicians.

## Achievements

- Raised $9.2M in February 2025 to advance DREEVEN toward FDA trials.
- Selected for Techstars 2023 and NVIDIA Inception.
- Finalist in the Massachusetts MeHI Healthy Aging Challenge.
- Launched clinical validation with Boston University and MIT.
- Built a sub-3kg self-supporting motorized knee orthosis.

## Latest updates

- **2025-02** — REEV raised $9.2M to finalize DREEVEN's design, run a clinical study at Boston University's Sargent College and prepare for FDA trials.
- **2025-12** — Established a Neuro-Integration Program with Stroke Centers of Excellence to prepare DREEVEN's clinical introduction.
- **2026** — Preparing a Series A round while advancing clinical work with MIT and Boston University.

## Links

- Website: https://reev.care
- LinkedIn: http://www.linkedin.com/company/reevcare
- Twitter/X: https://twitter.com/wearereev
- Instagram: https://www.instagram.com/wearereev/

---

Profile page: https://yespress.io/reev
Published by YesPress — https://yespress.io
Last updated: 2026-06-13